Clinical impacts of mesothelin expression in gastrointestinal carcinomas
Authors:
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Pathophysiology
- Vol. 7 (2) , 218-222
Abstract
Clinical impacts of mesothelin expression in gastrointestinal carcinomasKeywords
This publication has 35 references indexed in Scilit:
- C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinomaJournal of Gastroenterology, 2013
- Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinomaCancer Science, 2012
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1PClinical Cancer Research, 2009
- Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3Molecular Cancer Research, 2008
- Localization of Mesothelin in Epithelial Ovarian CancerApplied Immunohistochemistry & Molecular Morphology, 2005
- Mesothelin-family proteins and diagnosis of mesotheliomaThe Lancet, 2003
- Application of Mesothelin Immunostaining in Tumor DiagnosisAmerican Journal of Surgical Pathology, 2003
- Value of Mesothelin Immunostaining in the Diagnosis of MesotheliomaLaboratory Investigation, 2003
- Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)2001
- Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.Proceedings of the National Academy of Sciences, 1996